LOX expression did not correlate significantly with tumour stage, tumour size, lymph node status, progesterone receptor status, HER2 status, or G473A genotype, in agreement with our analysis of breast cancer cell lines (Fig. 3AB; see above). This evidence concerns the gene LOX and breast carcinoma.